Lyrica Oral Disintegrating Tablet 150mg (Pregabalin)

Adult dosage

This medication is taken orally without regard to food, dividing the total daily dosage into two doses per day, and is swallowed without water once it disintegrates on the tongue. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose is 150 mg per day, can increase to 300 mg per day after 3-7 days, and may reach a maximum of 600 mg per day. - Central Neuropathic Pain: Starting dose is 150 mg per day, can adjust to 300 mg per day after 1 week.

Children's dosage

Due to insufficient safety and efficacy data for children under 12 years and adolescents aged 12 to 17, administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if any changes in mood or behavior occur during treatment, consult a doctor immediately. People who are allergic to any component of this medication should not take it. Diabetic patients may experience weight gain while taking this medication, and dose adjustments for blood glucose control medications may be necessary. If symptoms of angioedema, such as swelling of the face or around the neck, occur, stop taking the medication immediately. Caution is necessary for elderly patients due to the risk of falling or injury from dizziness or drowsiness, especially when starting treatment. This medication may temporarily cause blurred vision or changes in eyesight; consult a doctor if these symptoms occur. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headaches, or anxiety; therefore, dosing should be adjusted according to a doctor’s instructions. Patients with a history of drug abuse should be cautious as there may be a potential for abuse of this medication. Patients with reduced kidney function may need dose adjustments for this medication. Patients with heart disease should be cautious as heart failure symptoms may occur after taking this medication. Caution is advised when taking this medication alongside opioid analgesics, as it may increase the risk of central nervous system and respiratory depression. Women of childbearing age should use effective contraception due to the risk of fetal malformation in early pregnancy, and use during pregnancy should be discussed with a doctor. If breastfeeding, this medication may pass into breast milk, so it is advised to either discontinue breastfeeding or consult a doctor regarding stopping the medication. Before driving or operating dangerous machinery, verify whether this medication causes dizziness or drowsiness; if symptoms appear, avoid such activities. In the case of overdose, symptoms such as confusion, drowsiness, depression, and seizures may occur, and immediate medical attention is required. Keep this medication out of reach of children, and do not transfer it to other containers.

Serious side effects

• Hives
• severe swelling (edema)
• angioedema
• facial and mouth swelling
• symptoms of angioedema
• loss of consciousness
• psychiatric disorders
• blurred vision and changes in vision
• Stevens-Johnson syndrome
• toxic epidermal necrolysis

Mild side effects

• Dizziness
• drowsiness
• confusion
• spatial orientation disturbance
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

Store this medication in a sealed container to prevent the entry of air or humidity. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness and safety of the medication for a longer period.

Appearance

Pink oval oral disintegrating tablet

Package unit

30 tablets/PTP [10 tablets/PTP x 3], 100 tablets/PTP [10 tablets/PTP x 10]